Clinical Pharmacology of Antibody-Drug Conjugates: A Regulatory Perspective

Time: 4:40 pm
day: Day Two

Details:

  • Summary of clinical pharmacology studies/information submitted in support of BLA approvals of ADC products
  • Case study of regulatory interest
  • Closing remarks and recommendations

Speakers: